In a 71-week study, Nova Nordisk—creators of the popular weight loss drug Wegovy—says their oral semaglutide achieved nearly ...

New versions of drugs like Wegovy, Ozempic, Mounjaro and Zepbound, including pills, will be easier to take, more effective ...

In a significant leap for gene therapy, scientists have discovered a method to reprogram the pancreas to produce GLP-1 ...

This article was reviewed by Darragh O’Carroll, MD. Diabetes Medications for Weight Loss: What to Know Key takeaways: Some ...

This article was reviewed by Darragh O’Carroll, MD. Ozempic Alternatives for Weight Loss Key takeaways: Ozempic® alternatives for weight loss include the injections Wegovy®, Mounjaro®, Zepbound®, ...

Three new Cochrane reviews find evidence that GLP-1 drugs lead to clinically meaningful weight loss, though industry-funded studies raise concerns. Three new reviews from Cochrane have found that ...

Middle-class Indians trying to lose weight are embracing drugs such as Mounjaro, which is also used to treat diabetes in a ...

Future of weight loss drugs: Eli Lilly announced early clinical trial results of its next-generation anti-obesity drug ...

The Trump administration’s pact with drugmakers to lower the price of GLP-1 drugs could pave the way for millions more to ...

The deal, with Eli Lilly and Novo Nordisk, is expected to lower the price of obesity drugs to between $149 and $350 per month ...

President Donald Trump on Thursday announced a deal with drugmakers Eli Lilly and Novo Nordisk to lower prices for their ...

Trump, Eli Lilly and Novo Nordisk unveiled a deal to slash the prices of popular GLP-1 weight‑loss drugs for government health insurance programs, as well as for cash payers.